In vitro analysis of flufenamic acid activity against Candida albicans biofilms

International Journal of Antimicrobial Agents

Volumn 43, Issue 1, 2014, Pages 86-91

  Chavez Dozal, Alba A ^a,b   Jahng, Maximillian ^a   Rane, Hallie S ^b   Asare, Kingsley ^b   Kulkarny, Vibhati V ^b   Bernardo, Stella M ^a,b   Lee, Samuel A ^a,b  

^a NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Antifungal; Biofilm; Candida albicans; Flufenamic acid

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FLUFENAMIC ACID;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FUNGAL STRAIN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; XTT ASSAY;

ANTIFUNGAL; BIOFILM; CANDIDA ALBICANS; FLUFENAMIC ACID;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; FLUFENAMIC ACID; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY;

EID: 84890800911     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.08.018     Document Type: Article

References (15)

1. G. Ramage, S.P. Saville, D.P. Thomas, and J.L. López-Ribot Candida biofilms: an update Eukaryot Cell 4 2005 633 638
2. L.A. Mermel, B.M. Farr, R.J. Sherertz, I.I. Raad, N. O'Grady, and J.S. Harris Guidelines for the management of intravascular catheter-related infections Clin Infect Dis 32 2001 1249 1272
3. C.J. Walraven, and S.A. Lee Antifungal lock therapy Antimicrob Agents Chemother 57 2013 1 8
4. M.A.S. Alem, and L.J. Douglas Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans Antimicrob Agents Chemother 48 2004 41 47
5. M.A.S. Alem, and L.J. Douglas Prostaglandin production during growth of Candida albicans biofilms J Med Microbiol 54 2005 1001 1005
6. K.T. Rajan, A.G.S. Hill, A. Barr, and E. Whitwell Flufenamic acid in rheumatoid arthritis Ann Rheum Dis 26 1967 43 46
7. M.H. Micelli, S.M. Bernardo, and S.A. Lee In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms Int J Antimicrob Agents 34 2009 326 332
8. G. Ramage, and J.L. López-Ribot Techniques for antifungal susceptibility testing of Candida albicans biofilms Methods Mol Med 118 2005 71 79
9. L.M. Lichtenberger, Y. Zhou, V. Jayaraman, J.R. Doyen, R.G. O'Neil, and E.J. Dial Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine Biochim Biophys Acta 1821 2012 994 1002
10. S.P. Bachmann, G. Ramage, K. VandeWalle, T.F. Patterson, B.L. Wickes, and J.L. López-Ribot Antifungal combinations against Candida albicans biofilms in vitro Antimicrob Agents Chemother 47 2003 3657 3659
11. P. Uppuluri, J. Nett, J. Heitman, and D. Andes Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms Antimicrob Agents Chemother 52 2008 1127 1132
12. R. Kaur, I. Castano, and B.P. Cormack Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria Antimicrob Agents Chemother 48 2004 1600 1613
13. M.A. Lew, K.M. Beckett, and M.J. Levin Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B J Infect Dis 136 1977 263 270
14. D.A. Stevens, M. Ichinomiya, Y. Koshi, and H. Horiuchi Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for β-1,6-glucan synthesis inhibition by caspofungin Antimicrob Agents Chemother 50 2006 3160 3161
15. E.G. Lentjes, and C.A. van Ginneken Pharmacokinetics of flufenamic acid in man Int J Clin Pharmacol Ther Toxicol 25 1987 185 187